Fast Five Quiz: Relapsed/Refractory Marginal Zone Lymphoma

Christina Poh, MD

November 03, 2021

Marginal zone lymphoma (MZL) describes a heterogeneous group of indolent lymphoproliferative disorders derived from post–germinal center marginal zone B cells. It is further categorized into subtypes on the basis of predominant area of disease involvement. Extranodal MZL of mucosa-associated lymphoid tissue (known as MALT lymphoma) primarily affects extranodal tissues, whereas nodal and splenic MZL primarily affects the lymph nodes and spleen, respectively. Treatment approach is dependent on MZL subtype.

How should relapsed/refractory MZL be treated? Test your knowledge with this quick quiz.

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Christina Poh. Fast Five Quiz: Relapsed/Refractory Marginal Zone Lymphoma - Medscape - Nov 03, 2021.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Fast Five Quiz: Relapsed/Refractory Marginal Zone Lymphoma

Tables

Authors and Disclosures

Authors and Disclosures

Author(s)

Christina Poh, MD

Comments

Email This

Feedback